Edition:
United States

Moleculin Biotech Inc (MBRX.A)

MBRX.A on American Stock Exchange

1.18USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$1.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,361
52-wk High
$3.13
52-wk Low
$0.87

About

Moleculin Biotech, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, which it refers to as Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia (AML).... (more)

Overall

Beta: --
Market Cap(Mil.): $54.61
Shares Outstanding(Mil.): 45.19
Dividend: --
Yield (%): --

Financials

  MBRX.A Industry Sector
P/E (TTM): -- 30.29 34.03
EPS (TTM): -0.51 -- --
ROI: -73.64 13.03 12.70
ROE: -79.37 14.20 17.29

Earnings vs. Estimates